Wallace Max N. 4
4 · Humacyte, Inc. · Filed May 21, 2024
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Wallace Max N.
Director
Transactions
- Purchase
Common Stock
2024-05-20$6.29/sh+3,990$25,097→ 3,990 total(indirect: By IRA) - Purchase
Common Stock
2024-05-20$6.21/sh+4,015$24,933→ 4,015 total(indirect: By IRA)
Holdings
- 56,550
Common Stock